Ado-trastuzumab emtansine Intravenous and Indacaterol and Glycopyrrolate
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Indacaterol and Glycopyrrolate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: glycopyrrolate / indacaterol
Brand name: Utibron Neohaler
Synonyms: Glycopyrrolate and indacaterol (inhalation)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Indacaterol and glycopyrrolate Inhalation
- Ado-trastuzumab emtansine Intravenous-Indacaterol inhalation
- Ado-trastuzumab emtansine Intravenous-Indacaterol Maleate
- Ado-trastuzumab emtansine Intravenous-Indapamide
- Ado-trastuzumab emtansine Intravenous-Inderal
- Ado-trastuzumab emtansine Intravenous-Inderal Intravenous
- Indacaterol and Glycopyrrolate-Adox Pak 2/100
- Indacaterol and Glycopyrrolate-Adoxa
- Indacaterol and Glycopyrrolate-Adoxa CK
- Indacaterol and Glycopyrrolate-Adoxa Pak
- Indacaterol and Glycopyrrolate-Adoxa Pak 1/100
- Indacaterol and Glycopyrrolate-Adoxa Pak 1/150